Cancer Immunotherapy Linked to Increased Risk of Severe Infections
Audio narration · Coming soon
A retrospective analysis of over 20,000 patient records has found that cancer immunotherapy may heighten the risk of severe infections in certain patients. This finding highlights the need for developing risk-mitigating strategies to improve patient safety during treatment.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews